BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4521 related articles for article (PubMed ID: 6440898)

  • 21. Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species.
    Fornstedt B; Rosengren E; Carlsson A
    Neuropharmacology; 1986 Apr; 25(4):451-4. PubMed ID: 3086766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presence of cysteinyldopa in the mature bovine eye.
    Dryja TP; Albert DM; Rosengren E; Reid TW
    Exp Eye Res; 1977 Nov; 25(5):459-64. PubMed ID: 598423
    [No Abstract]   [Full Text] [Related]  

  • 23. Evidence of dopa in the nerves of sea anemones.
    Carlberg M
    J Neural Transm; 1983; 57(1-2):75-84. PubMed ID: 6137512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopa and 5-S-cysteinyldopa in the serum of albino, black, and red guinea pigs.
    Hansson C; Agrup G; Rorsman H; Rosengren E
    Acta Derm Venereol; 1980; 60(2):155-56. PubMed ID: 6155023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-S-cysteinyldopa in diagnosis and treatment of human malignant melanomas and ultrastructural observations.
    Aubert C; Rosengren E; Rorsman H; Rouge F; Foa C; Lipcey C
    Eur J Cancer (1965); 1977 Nov; 13(11):1299-308. PubMed ID: 590287
    [No Abstract]   [Full Text] [Related]  

  • 26. Plasma 5-S-cysteinyldopa concentrations in oculocutaneous albinism.
    Nimmo JE; Hunter JA; Percy-Robb IW; Jay B; Phillips CI; Taylor WO
    Acta Derm Venereol; 1985; 65(2):169-71. PubMed ID: 2408424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of 5-S-L-cysteinyl-glycine-L-dopa, a natural substrate for serum and melanocyte dipeptidase.
    Kågedal B; Gawelin AL; Pettersson A
    Anal Biochem; 1987 Aug; 165(1):167-74. PubMed ID: 3120620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of 3,4-dihydroxyphenylalanine (DOPA) in plasma and cerebrospinal fluid by high performance liquid chromatography with electrochemical detection.
    Boomsma F; van der Hoorn FA; Man in 't Veld AJ; Schalekamp MA
    Clin Chim Acta; 1988 Nov; 178(1):59-69. PubMed ID: 3147824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glutathionedopa in malignant melanoma.
    Agrup G; Falck B; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1977; 57(3):221-2. PubMed ID: 71825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection and quantitation of 5-S-cysteinyldopa in melanotic and amelanotic melanoma in comparison with nonpigment cell tumors and it's urinary excretion.
    Mojamdar M; Ichihashi M; Mishima Y
    J Dermatol; 1979 Dec; 6(6):379-82. PubMed ID: 120380
    [No Abstract]   [Full Text] [Related]  

  • 31. Urinary 5-S-cysteinyldopa in Parkinsonism after DOPA and carbidopa.
    Stewart RM; Miller S; Gunder M
    Acta Derm Venereol; 1983; 63(2):97-101. PubMed ID: 6189350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis of amelanotic malignant melanoma by means of the fluorescence method (Falck & Hillarp) and determination of 5-S-cysteinyldopa in the lesions].
    Morishima T; Fukada E; Nagashima N
    Nihon Hifuka Gakkai Zasshi; 1983 Jan; 93(1):51-4. PubMed ID: 6408288
    [No Abstract]   [Full Text] [Related]  

  • 33. Characterization of structural properties for morphologic differentiation of melanosomes. III. free and protein-bound dopa and 5-S-cysteinyldopa in B16 and Harding-Passey melanomas.
    Ito S; Homma K; Kiyota M; Fujita K; Jimbow K
    J Invest Dermatol; 1983 Mar; 80(3):207-9. PubMed ID: 6402551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary excretion of 5-S-cysteinyldopa in healthy Japanese.
    Morishima T; Hanawa S
    Acta Derm Venereol; 1981; 61(2):149-50. PubMed ID: 6165192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of 5-S-cysteinyldopa in human urine by direct injection in coupled-column high-performance liquid chromatography.
    Hansson C; Kågedal B; Källberg M
    J Chromatogr; 1987 Sep; 420(1):146-51. PubMed ID: 3117824
    [No Abstract]   [Full Text] [Related]  

  • 36. Rapid and simple analysis of DOPA and 5-HTP using high performance liquid chromatography with electrochemical detection.
    Arnerić SP; Goodale DB; Flynn JR; Long JP
    Brain Res Bull; 1981 May; 6(5):407-11. PubMed ID: 6454458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-S-cysteinyldopa in the urine of melanoma patients.
    Agrup G; Agrup P; Andersson T; Falck B; Hansson JA; Jacobsson S; Rorsman H; Rosengren E; Rosengren AM
    Acta Derm Venereol; 1977; 57(2):113-6. PubMed ID: 71802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Derivation of urinary dopamine from plasma dopa.
    Zimlichman R; Levinson PD; Kelly G; Stull R; Keiser HR; Goldstein DS
    Clin Sci (Lond); 1988 Nov; 75(5):515-20. PubMed ID: 3151165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-S-cysteinyldopa as a substrate for tyrosinase.
    Hansson C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1980; 60(5):399-402. PubMed ID: 6162310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of melanogenesis in mouse and guinea pig hair by chemical analysis of melanins and of free and bound dopa and 5-S-cysteinyldopa.
    Ito S; Fujita K; Takahashi H; Jimbow K
    J Invest Dermatol; 1984 Jul; 83(1):12-4. PubMed ID: 6429251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 227.